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An alternative approach for the control of fungal 
diseases of banana, such as black Sigatoka, the most 
important disease affecting this crop in the world, is 
the development of transgenic plants with resistance 
against Mycosphaerella fijiensis (Chakrabarti et al., 
2000). In different plant species the more commonly 
used genes for this purpose are those coding for 
hydrolytic enzymes such as chitinases and glucanases 
(Gómez et al., 2004; Sreeramanan et al., 2006), 
elicitors of plant defense responses (Strittmatter 
et al., 1995; Keller et al., 1999) and antimicrobial 
peptides (AMPs) (Shah, 1997; Cary et al., 2000; 
Li et al., 2001; Kawata et al., 2003; Osusky et al., 
2004; Xing et al., 2006; Sher et al., 2006). AMPs are 
attractive candidates for transgenic applications for 
several reasons: their diverse antimicrobial activity, its 
low toxicity for non-target cells and their probable low 
cost in terms of energy and biomass involved in their 
expression (Boman, 1991).
Several AMPs have been extensively studied, 
including maganins, melittins and plant defensins. 
Some studies have demonstrated that cecropins 
and their derivatives (Cary et al., 2000; Rajasekaran 
et al., 2001) as well as a cecropin-melittin hybrid 
(Osusky et al., 2000), are capable of inhibiting the in 
vitro growth of different important plant pathogenic 
fungi (Osusky et al., 2000).
Banana transgenic lines expressing Dm-AMP1 and 
Ace-AMP were reported to increase tolerance to 
Colletotrichum musae under laboratory conditions 
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Abstract. The interest in the use of antimicrobial peptides to 
control fungal diseases in banana plants has been rising in the last 
years. In this paper we analyzed the antifungal activity of different 
peptides on the in vitro development of Mycosphaerella 
fijiensis and found that they inhibited fungal mycelial growth and 
ascospore germination. All peptides evaluated displayed activity 
against the fungus although with marked differences in IC50 values 
ranging between 3.06 and 239.61 µg/mL. The peptides exhibiting 
better activity were the designated peptides Ib-AMP4 and Ib-AMP2, 
both derived from Impatiens balsamina. Furthermore, the in 
vitro activity of these peptides seemed compatible with existing 
chemical fungicides, having no antagonistic or synergistic effect 
with these agents. The effect of these peptides on M. fijiensis 
mycelial elongation and ascospores germination suggests that 
they can be used as potential alternative strategies for the control 
of black Sigatoka disease.
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Resumen. El interés en el uso de péptidos antimicrobianos para 
el control de enfermedades de hongos en plantas de banano ha 
aumentado en los últimos años. En este trabajo se analizó la 
actividad antifúngica de diferentes péptidos sobre el desarrollo 
in vitro de Mycosphaerella  fijiensis y se encontró que 
estos inhiben el crecimiento micelial del hongo y la germinación 
de sus ascosporas. Todos los péptidos evaluados mostraron 
actividad contra el hongo, aunque con marcadas diferencias en 
los valores de IC50  los cuales variaron entre 3,06 y 239,61 µg/
mL. Los péptidos que presentaron mayor actividad fueron los 
designados Ib-AMP4 e Ib-AMP2, ambos derivados de la planta 
Impatiens balsamina. De otro lado, la actividad in vitro de 
estos péptidos parece ser compatible con algunos fungicidas 
químicos ya que cuando se usaron en forma combinada, no se 
encontraron efectos antagónicos o sinérgicos con estos agentes. 
Los hallazgos sugieren que los péptidos antimicrobianos podrían 
ser utilizados como posibles estrategias alternativas para el 
control de la Sigatoka negra. 
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(Remy, 2000). Chakrabarti et al. (2003) reported 
the successful expression of a synthetic peptide in 
banana plants showing increased resistance to both 
Fusarium oxysporum f.sp. cubense and M. musicola 
(Chakrabarti et al., 2003).
In view of the great variety of existing antimicrobial 
peptides and their diverse spectrum of activity, 
in vitro evaluations of particular peptides to any 
given pathogen would be important to improve 
the probability of success and to lower costs in 
the transgenic approach. Additionally, the in vitro 
analysis could also allow determination of interactions 
between peptide mixtures or between peptides and 
other substances, such as chemical fungicides.
In this work we determined the in vitro activity of 
six AMPs against M. fijiensis, the causative agent 
of black Sigatoka, by studying their effect on the 
development of fungal mycelium and ascospore 
germination. Moreover, we also evaluated 
interactions of AMPs with three fungicides: Benomyl, 
Propiconazol, Azoxystrobin. The data obtained 
allowed to determine which AMPs appeared to be 
good candidates to develop transgenic banana 
plants with possible resistance to the black Sigatoka.
MATERIALS AND METHODS
Fungal isolates and AMPs. Evaluations were 
carried out with two monosporic strains (codes 
No. 205001 and 205019) of M. fijiensis previously 
isolated from infected banana leaves according 
to standard procedures (Smith et al., 1991a). 
Strains were kept in PDA (Becton Dickinson and 
Company, Le Pont de Claix, France) at 25±2 °C. 
The identity of each strain was confirmed by the 
morphological characteristics of their conidia and 
by PCR (Polymerase Chain Reaction), using specific 
primers (Johanson y Jeger, 1993).
The peptides used, shown in Table 1, were synthesized 
by the Fundación Instituto de Inmunología de 
Colombia (FIDIC) (Bogotá, Colombia) by chemical 
synthesis based on published sequences. Ib-AMPs 1 
to 4 are peptides derived from Impatiens balsamina 
(Tailor et al., 1997). CEMA is composed of 8 amino 
acid residues derived from melittin at its C-terminal 
end, and 16 amino acids derived from cecropin at 
its N-terminus. MrsA1 is the same as CEMA but with 
an extension of 6 amino acids at the N-terminus 
(Osusky et al., 2000).
Table 1. Sequence of the evaluated antimicrobial peptides 
Name Origin Sequence
CEMA Synthetic(cecropin A/ melittin hybrid)1 KWKLFKKIGIGAVLKVLTTGLPALKLTK
MsrA1 Synthetic( Modified form of CEMA)1 MALEHMKWKLFKKIGIGAVLKVLTTGLPALKLTK
Ib-AMP1 Impatiens balsamina GRRCCGWGPGRRYCVRWC
Ib-AMP2 Impatiens balsamina GRRCCNWGPGRRYCKRWC
Ib-AMP3 Impatiens balsamina RHRCCAWGPGRKYCKRWC
Ib-AMP4 Impatiens balsamina GRRCCGWGPGRRYCRRWC
1Osusky et al., 2004.
The peptides were dissolved in deionised water before 
their use and maintained at 4 °C. Initially, these 
peptides were assayed at concentrations varying 
from 1, to 80 µg/mL depending on test results. 
Concentrations were adjusted by trial and error until 
reaching the data presented. 
Antifungal assays
Activity against mycelial growth. Antifungal tests 
were done according to Peláez et al. (2006). Briefly, M. 
fijiensis, mycelium was scraped from agar cultures and 
re-suspended in 5 mL of distilled water, fragmented 
with glass beads (Schott, Wertheim, Germany), using 
a vortex and passed through an etamine cloth (aprox 
100 μm pores). Mycelial fragments concentration 
was measured in a Neubauer chamber (1/10 mm 
deep, bright line-Boeco, Germany) and adjusted 
with water to 10 x 104 fragments /mL. The effect 
of peptides on mycelial growth was evaluated in 
covered flat bottomed 96-wells microplates (Falcon 
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Becton Dickinson 35-3075 Franklin Lakes, NJ. USA) 
by adding to each well 30 µL of Sabouraud dextrose 
broth (Beckton Dickinson and Company, Le Pont de 
Claix, France); 30 µL of mycelial suspension and 30 
µl of the different peptide concentrations. The plate 
was incubated at room-temperature 25±2 ºC for 
8 days and the mycelial growth was measured by 
the increase in absorbance determined in an ELISA 
Reader (Biorad model 550, Tokyo, Japan) at 595 nm. 
Each test was run three times separately, and each 
concentration was evaluated in triplicate. From these 
data, the percentage of inhibition for each substance 
was determined and the 50% Inhibiting Concentration 
(IC50) calculated considering as 100% the growth 
in the control wells not containing AMP. Statistical 
significance of the results was determined by ANAVA 
with a restrictive random block design. Individual 
means were compared using the Tukey test with a 
95% significance level.
Evaluation of the effect on ascospore 
germination. A modification of the traditional 
ascospore germination evaluation method was used 
(Smith et al., 1991a). Banana leaves at advanced 
stages of infection with black Sigatoka were set for 
ascospore discharge over plastic polypropylene circles 
placed on Petri dishes containing water-granulated 
agar 2%. Sites of ascospore discharge were located 
and marked using a light microscope and 20 µL of 
each peptide solution at a concentration of 40 mg/L 
for peptides 24892, 24893, 24894, 24895 (over 
IC75 when evaluated with strain 205001) and 80 
mg/l for peptides 24890 y 24891 (highest evaluated 
concentration) were placed over the ascospores. Plates 
were then incubated for 48 h at 25±2 °C in a humid 
chamber and ascospore germination percentage was 
determined by counting 60 spores per plate under 
the light microscope at 40X. Ascospore germination 
was evaluated qualitatively, considering normal 
germination is bipolar and has no ramifications. 
Comparisons were made with the growth in a control 
of ascospores covered only with peptide solvent.
Evaluation of the in vitro interaction between 
peptides and chemical fungicides. The in vitro 
interaction between peptides and the chemical 
fungicides Propiconazole, Benomyl and Azoxystrobin 
was evaluated using the same method described 
before for the evaluation of activity against mycelial 
growth but using combinations of the different 
compounds at their respective IC25, IC50 and IC75 
concentrations. It was, therefore, necessary to 
determine the inhibitory concentrations for all the 
chemical fungicides used. The 205019 isolate was 
considered to be resistant to Benomyl as it grows at 
concentrations higher than 10 mg/l of this fungicide 
(Smith et al., 1991b). In order to determine a possible 
synergistic or antagonistic effect a modified Limpel’s 
formula Ee=(X+Y)–(XY/100) was used, where Ee is 
the expected effect from an additive response and 
X and Y are the relative inhibitory percentages of 
each compound when applied independently. In this 
tests, if the combination of the 2 agents produces any 
value higher than Ee, it is considered that there is a 
synergistic effect (Richer, 1987).
RESULTS AND DISCUSSION
Effect of AMPs over mycelial growth. Mycelial 
growth inhibition tests revealed that some of the 
peptides displayed antifungal activity against M. 
fijiensis at different degrees. The IC50 values of 
the different peptides on strain 205001 were in a 
range from 3.06 to 239.61 µg/mL, and for strain 
205019 from 5.06 to 19.48 µg/mL. In general, it 
was observed that the peptides from I. balsamina 
(Ib-AMP 1 -4) displayed greater activity than CEMA 
and MrsA1 (Osusky et al., 2004), which had IC50s 
between 12.60 µg/mL up to 239.61µg/mL.
Additionally, there were significant differences among 
the activities of the peptides from I. balsamina, the 
best being Ib-AMP4, with an IC50 value of 3.06 
µg/mL for strain 205001 and 5.06 µg/mL for strain 
205019 (Table 2), followed by Ib-AMP2(5.084 µg/mL 
and 13,84 µg/mL) and Ib-AMP1 (10.11 µg/mL and 
16,97 µg/mL). This last peptide had was used by 
Remy (2000) to generate transgenic banana plants 
but, no activity against M. fijiensis was determined. 
It has been speculated that the differences in 
activity observed for individual Ib-AMPs are due to 
differences in the net charge of the peptides and 
that a correlation with the charge present in the wall 
of the target fungus exist. This speculation comes 
from the observation that a reduction in antifungal 
activity in media of increased ionic strength is 
a common feature of most of the small cationic 
peptides isolated to date, and probably reflects the 
weakening of electrostatic interactions with the 
target rather than any alteration of the structure of 
the peptide by the binding of ions from the medium. 
This is supported by the fact that the degree of 
reduction in antifungal activity is dependent on the 
test fungus (Tailor et al., 1997).
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Table 2. Inhibition of mycelial growth of Mycosphaerella fijiensis: inhibitory concentrations achieved by the 
different peptides. 
1. Peptide 2. Strain: 205001 3. Strain: 205019
µg/mL µg/mL
IC25 IC50 IC75 IC25 IC50 IC75
CEMA 9.69 49.29 a 75.62 4.20 11.99 a c 37.79
MsrA1 22.17 144.60 b 2589.68 7.36 24.77 b 51.59
Ib-AMP1   5.30 10.11 a 28.69 5.88 16.97 ab 35.24
Ib-AMP2   2.21 5.08 a 18.47 5.70 13.84 ab 30.95
Ib-AMP3    6.50 16.63 a 33.06 5.86 18.93 ab 40.86
Ib-AMP4    0.85 3.21a 11.00 1.69 4.68 c  15.17
Values that share the same letter in the same column are not statistically different according to Tukey’s test (P= 0.05)
Considering the interactions related to net charges 
described above, an evaluation of the antifungal 
activity of these peptides against M. fijensis isolate 
205001 was done in Tris-HCL at pHs 3.5. 4.5, 5.5, 
6.5 and 7.5. No statistical differences were found 
between the different pHs used (data not shown), 
indicating that  antifungal activity is not altered at 
these pH ranges.
Despite the fact that CEMA has been reported as 
a good candidate to generate transgenic plants 
with resistance against fungi, the data obtained in 
this study showed little in vitro activity against M. 
fijiensis. Mrsa1 was the peptide with the lower activity 
against M. fijiensis from all products evaluated. It is 
possible that other melittin /cecropin hybrids could 
have had better activity against this fungus since it 
has been reported that some hybrids can show an 
increase up to 100 times in their relative inhibitory 
activity (Osusky et al., 2000).
Effect of AMPs over ascospore germination. Due 
to limitations in the available amount of peptides and 
to technical difficulties to evaluate different peptide 
concentrations, the effect of peptides on ascospore 
germination was studied only at concentrations of 
40 and 80 µg/mL as they matched or exceeded the 
IC75 calculated on the same data as above. At these 
concentrations all peptides tested caused abnormal 
multiple germ tube elongation, while the control which 
contained only solvent (water) showed the characteristic 
bipolar germ tube elongation pattern (Figure 1). These 
results confirm the inhibitory effect of AMP peptides 
against M. fijiensis and suggest a similar action mechanism 
despite of the structural differences among the Ib-AMPs 
and the melittin/cecropin hybrids (CEMA y MrsA1).
A B C
Figure 1. Effect of the peptides over ascospore germination of Mycosphaerella fijiensis. A. Non-germinating 
ascospores in the presence of peptide Ib-AMP4. B. Ascospores with normal germination (negative control). C. 
Ascospores with abnormal germination in presence of the chemical fungicide Benomyl (positive control). Ascospores 
were observed under light microscope at 40X after 48 hours post incubation with the respective treatment.
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Cysteine-rich antimicrobial peptides have been 
previously demonstrated to inhibit specific cellular 
processes and cause abnormal germ tube formation 
in several fungi by binding to glucosylceramides, 
a specific membrane sphingolipid which act as 
a receptor for the peptides (Lee et al., 1999; 
Thevissen et al., 2004). It has also been observed 
that fungal susceptibility might be related to 
specific sphingolipid mannosyl diinositolphosphoryl 
ceramide biosynthesis. Yeast mutants revealed that 
expression of two genes involved on sphingolipids 
biosynthesis, IPT1 and SKN1, leaded to an increase 
on susceptibility to γ-thionin DmAMP1 (Thevissen et 
al., 2005).The disruption of the normal ascospore 
germination patterns suggests a similar action 
mechanism of these peptides in M. fijiensis.
Combinations of AMPs and chemical fungicides. 
Several combinations of AMPs with the most 
commonly used chemical fungicides in the control of 
the disease were evaluated. As seen in Table 3, all the 
experiments combining AMPs and chemical fungicides 
showed an additive effect, as expected values (Ee) 
were similar to the inhibitory values recorded for each 
mixture. These results rule out a synergic or antagonist 
effect for all combinations with an exception in the 
results corresponding to the highest concentration of 
Propiconazole (IC75) where a small but not significant 
antagonistic effect with CEMA was observed. The 
results obtained in these assays suggest that the use 
of antimicrobial peptides could be compatible with 
control strategies based on chemical fungicides and 
that it may be possible to combine the transgenic 
approach with the use of fungicides.
Table 3. Antimicrobial peptides and agrochemicals: concentrations evaluated to determine the effect of various 
combinations in the control of black Sigatoka disease.
Evaluated 
substance (IC)* Percentage of inhibition
Evaluated 









CEMA (P1) Ib-AMP4 (P2)
P1-25 6.90 (0-14.05) P2-25 11.95 (5.11-18.79)
P1-50 8.41 (0-25.04) P2-50 46.53 (19.19-73.85)
P1-75 64.89 (45.65-84.13) P2-75 99.21 (98.35-100)
Propiconazole (T)
T25 44.92 (16.66-73.17) T25 36.57 (15.46-57.68) 
T50 95.98 (91.47- 100) T50 96,72 (92.51-100)
T75 98,07 (96.93- 99.22) T75 99.34 (98.51-100)
P1-25: T25 37.40 (12.93-61.88) 48.72 P2-25: T25 44.30 (27.97-60.22) 44.15
P1-50: T25 45.14 (21.37-68.93) 49.55 P2-50: T25 74.61 (45.90-100) 66.08
P1-75: T25 85,75 (75.12-96.37) 80.66 P2-75: T25 99.25 (98.44-100) 99.49
P1-25: T50 90,04 (74.77-100) 97.48 P2-25: T50 85.38 (64.04-100) 97,11
P1-50: T50 91,72 (85.34-98.11) 97,79 P2-50: T50 88.91 (73.64-100) 98,25
P1-75: T50 96,35 (93.54-99.17) 99,42 P2-75: T50 98.67 (97.71-99.63) 99,97
P1-25: T75 98,06 (96.88-99.25) 99,80 P2-25: T75 99.52 (98.94-100) 99.41
P1-50: T75 97,47 (95.94-98.99) 99,84 P2-50: T75 99.49 (98.75-100) 99.65
P1-75: T75 97,20 (95.52-98.89) 99,92 P2-75: T75 99.02 (97.88-100) 99.99
Azoxystrobin (BK)
BK25 17.16 (5.93-28.39) BK25 13.92 (1.37-26.47)
BK50 29.03 (16.12-41.94) BK50 38.59 (27.44-49.75)
BK75 66.31 (56.04-76.57) BK75 62.91 (54.02-71.81)
P1-25: BK25 23.60 (10.49-36.71) 22.87 P2-25: BK25 14.52 (4.38-24.65) 24.21
P1-50: BK25 28.21 (15.73-40.69) 24.13 P2-50: BK25 49.37 (29.04-69.70) 53.97
P1-75: BK25 68.71 (58.52-78.90) 70.91 P2-75: BK25 98.88 (98.16-99.60) 99.32
P1-25: BK50 34.56 (22.70-46.42) 33.93 P2-25: BK50 40.95 (30.93-50.97) 47.07
P1-50: BK50 46.03 (41.41-50.66) 35.00 P2-50: BK50 63.96 (45.51-82.41) 71.61
P1-75: BK50 86.90 (80.66-93.14) 75.08 P2-75: BK50 98.30 (97.39-99.21) 100
P1-25: BK75 63.51 (54.19-72.82) 68.63 P2-25: BK75 59.25 (46.41-72.09) 67.34
P1-50: BK75 70.61 (63.41-77.81) 69.14 P2-50: BK75 85.21 (76.44-93.98) 80.17
P1-75: BK75 93.01 (87.50-98.52) 88.17 P2-75: BK75 97.47 (96.42-98.53) 99.71
Benomyl (B)
B25 51.62 (30.94-72.30) B25 48.44 (23.16-73.73)
B50 81.77 (58.66-100) B50 94,43 (84.60-100)
P1-25: B25 47.09 (25.74-68.43) 54.96 P2-25: B25 63.74 (40.04-87.45) 54.60
P1-50: B25 71.45 (54.54-88.36) 55.69 P2-50: B25 72.86 (45.40-100) 72.43
P1-75: B25 99.20 (98.47-99.93) 83.01 P2-75: B25 100 (100-100) 99.59
P1-25: B50 95.22 (89.14-100) 83.02 P2-25: B50 84.37 (64.33-100) 95,09
P1-50: B50 98.76 (97.6-99.92) 83.30 P2-50: B50 90.57 (76.98-100) 97,02
P1-75: B50 99,49 (99.06-99.91) 93.60 P2-75: B50 99.80 (99.55-100) 99,95
* IC: Inhibitory concentration values obtained by lineal regression. 
ŧ Ee , Expected value for an additive response according to Limpel equation, expressed in percentage of inhibition. 
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CONCLUSION
Recently, there has been a lot of interest in the use 
of antimicrobial peptides to confer resistance to 
diseases in banana plants (Remy et al., 1998; Gómez 
et al., 2002; Chakrabarti et al., 2003). In this work 
we determined the antifungal activity of different 
peptides on the in vitro development of M. fijiensis. 
The results presented in this work show that AMPs 
were capable of inhibiting fungal mycelial growth 
and ascospore germination. Although all peptides 
evaluated displayed activity against the fungus, there 
were differences among them. The peptide with 
better activity was Ib-AMP4, followed by Ib-AMP2. The 
effect of antimicrobial peptides on mycelial elongation 
and ascospore germination, support the notion that 
these substances may represent potential alternative 
strategies for the control of black Sigatoka disease.
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